191 related articles for article (PubMed ID: 15390084)
1. Effective use of preparative chiral HPLC in a preclinical drug synthesis.
Nelson TD; Welch CJ; Rosen JD; Smitrovich JH; Huffman MA; McNamara JM; Mathre DJ
Chirality; 2004 Nov; 16(9):609-13. PubMed ID: 15390084
[TBL] [Abstract][Full Text] [Related]
2. Strategic use of preparative chiral chromatography for the synthesis of a preclinical pharmaceutical candidate.
Leonard WR; Henderson DW; Miller RA; Spencer GA; Sudah OS; Biba M; Welch CJ
Chirality; 2007 Sep; 19(9):693-700. PubMed ID: 17354260
[TBL] [Abstract][Full Text] [Related]
3. Preparative chromatographic resolution of racemates using HPLC and SFC in a pharmaceutical discovery environment.
Miller L; Potter M
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Nov; 875(1):230-6. PubMed ID: 18639504
[TBL] [Abstract][Full Text] [Related]
4. Preparative separation and identification of derivatized beta-methylphenylalanine enantiomers by chiral SFC, HPLC and NMR for development of new peptide ligand mimetics in drug discovery.
Nogle LM; Mann CW; Watts WL; Zhang Y
J Pharm Biomed Anal; 2006 Mar; 40(4):901-9. PubMed ID: 16239092
[TBL] [Abstract][Full Text] [Related]
5. The application of preparative batch HPLC, supercritical fluid chromatography, steady-state recycling, and simulated moving bed for the resolution of a racemic pharmaceutical intermediate.
Yan TQ; Orihuela C; Swanson D
Chirality; 2008 Feb; 20(2):139-46. PubMed ID: 18092299
[TBL] [Abstract][Full Text] [Related]
6. Enantioselective chromatography in drug discovery.
Zhang Y; Wu DR; Wang-Iverson DB; Tymiak AA
Drug Discov Today; 2005 Apr; 10(8):571-7. PubMed ID: 15837600
[TBL] [Abstract][Full Text] [Related]
7. Zinc carbenoid-mediated chain extension: preparation of alpha,beta-unsaturated-gamma-keto esters and amides.
Ronsheim MD; Zercher CK
J Org Chem; 2003 May; 68(11):4535-8. PubMed ID: 12762764
[TBL] [Abstract][Full Text] [Related]
8. Rapid screening of enzymes for the enzymatic hydrolysis of chiral esters in drug discovery.
Petucci C; Di L; McConnell O
Chirality; 2007 Sep; 19(9):701-5. PubMed ID: 17575571
[TBL] [Abstract][Full Text] [Related]
9. Supercritical fluid chromatography for the enantioseparation of pharmaceuticals.
De Klerck K; Mangelings D; Vander Heyden Y
J Pharm Biomed Anal; 2012 Oct; 69():77-92. PubMed ID: 22366324
[TBL] [Abstract][Full Text] [Related]
10. Biocatalysis: synthesis of chiral intermediates for drugs.
Patel RN
Curr Opin Drug Discov Devel; 2006 Nov; 9(6):741-64. PubMed ID: 17117684
[TBL] [Abstract][Full Text] [Related]
11. Parallel supercritical fluid chromatography/mass spectrometry system for high-throughput enantioselective optimization and separation.
Zeng L; Xu R; Laskar DB; Kassel DB
J Chromatogr A; 2007 Oct; 1169(1-2):193-204. PubMed ID: 17900596
[TBL] [Abstract][Full Text] [Related]
12. "Fit-for-purpose" development of analytical and (semi)preparative enantioselective high performance liquid and supercritical fluid chromatography for the access to a novel σ1 receptor agonist.
Rossi D; Marra A; Rui M; Brambilla S; Juza M; Collina S
J Pharm Biomed Anal; 2016 Jan; 118():363-369. PubMed ID: 26600118
[TBL] [Abstract][Full Text] [Related]
13. Rapid and high throughput separation technologies--steady state recycling and supercritical fluid chromatography for chiral resolution of pharmaceutical intermediates.
Yan TQ; Orihuela C
J Chromatogr A; 2007 Jul; 1156(1-2):220-7. PubMed ID: 17449051
[TBL] [Abstract][Full Text] [Related]
14. Construction of quaternary stereocenters by efficient and practical conjugate additions to alpha,beta-unsaturated ketones with a chiral organic catalyst.
Wu F; Li H; Hong R; Deng L
Angew Chem Int Ed Engl; 2006 Jan; 45(6):947-50. PubMed ID: 16385604
[No Abstract] [Full Text] [Related]
15. Large scale chiral chromatography for the separation of an enantiomer to accelerate drug development.
Hsu LC; Kim H; Yang X; Ross D
Chirality; 2011 Apr; 23(4):361-6. PubMed ID: 21384442
[TBL] [Abstract][Full Text] [Related]
16. Enhanced chromatographic resolution of amine enantiomers as carbobenzyloxy derivatives in high-performance liquid chromatography and supercritical fluid chromatography.
Kraml CM; Zhou D; Byrne N; McConnell O
J Chromatogr A; 2005 Dec; 1100(1):108-15. PubMed ID: 16197954
[TBL] [Abstract][Full Text] [Related]
17. Stereoselective synthesis of (+)-nephrosteranic acid, (+)-trans-cognac lactone, and (+)-trans-whisky lactone using a chiral cyclohexadienyl Ti compound.
Schleth F; Vogler T; Harms K; Studer A
Chemistry; 2004 Sep; 10(17):4171-85. PubMed ID: 15352100
[TBL] [Abstract][Full Text] [Related]
18. Improving sensitivity in chiral supercritical fluid chromatography for analysis of active pharmaceutical ingredients.
Helmy R; Biba M; Zang J; Mao B; Fogelman K; Vlachos V; Hosek P; Welch CJ
Chirality; 2007 Nov; 19(10):787-92. PubMed ID: 17722016
[TBL] [Abstract][Full Text] [Related]
19. Supercritical fluid chromatography and steady-state recycling: phase appropriate technologies for the resolutions of pharmaceutical intermediates in the early drug development stage.
Yan TQ; Orihuela C; Preston JP; Xia F
Chirality; 2010 Nov; 22(10):922-8. PubMed ID: 20872668
[TBL] [Abstract][Full Text] [Related]
20. Use of (1)H NMR to facilitate solubility measurement for drug discovery compounds.
Lin M; Tesconi M; Tischler M
Int J Pharm; 2009 Mar; 369(1-2):47-52. PubMed ID: 19073245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
